Popular companies

Back to search results

Astellas Pharma Europe Ltd (Branch/Related Entity)

astellas.eu

Explore carbon emissions data for Astellas Pharma Europe Ltd (Branch/Related Entity). Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.

This profile brings together available carbon emissions data for Astellas Pharma Europe Ltd (Branch/Related Entity), including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.

Claim this company

Emissions

Carbon emissions

Structured data JSON-LD, Open Corporate Carbon Footprint Data Model Spreadsheet CSV

Open Corporate Carbon Footprint Data Model, by the Carbon Accounting Alliance with Murmurate Digital, Mycelium and Roundarc.

Total yearly emissions across all scopes

562,651 tCO2e

Scope 1

tCO2e

61,171

Scope 2

tCO2e

56,473

Scope 3 total

tCO2e

445,007

Scope 3 reported

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
view full emissions profile

Provenance

Review the sources and documents behind Astellas Pharma Europe Ltd (Branch/Related Entity)'s emissions data. Provenance matters because it shows where the information comes from, how recent it is and how complete the disclosure appears to be.

Documents

Cover of the source filing PDF Load PDF

Carbon accountant

–

Emissions
Factors

Modelled emission factor Total, all scopes including all Scope 3
– kgCO2e / £M

Supplier specific emission factors (kgCO2e / £M)

Modelled
Reported
Scope 1 + 2 Direct + purchased energy
–
–
Upstream + upstream Scope 3
–
–
Total + all Scope 3
–
–

Which figure should I use?

Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.

Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.

When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.

Sustainability
Snapshot

Based on reported data, retrieved with AI

  • Astellas Pharma Europe Ltd (Branch/Related Entity) reported 562,651 tCO₂e in 2022.
  • Scope 3 accounted for 79% of emissions.

According to available emissions disclosures, Astellas Pharma Europe Ltd (Branch/Related Entity) reported total yearly emissions of 562,651 tCO₂e in 2022. Scope 3 emissions accounted for 79% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.

The company achieved a Mycelium Score of –, pending a benchmark for its sector for sustainability performance, and received a transparency score of 10.0, pointing to very little public detail on their key emissions.

Total Emissions across all scopes

562,651 tCO2e

Scope 1 emissions

Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.

Direct emissions

61,171

tCO2e

Scope 2 emissions

Indirect emissions from purchased energy, including electricity, heating and cooling.

Location based

56,473

tCO2e

Market based

–

tCO2e

Scope 3 emissions

Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.

Cat 1

Purchased goods & services

–

tCO2e

Cat 2

Capital goods

–

tCO2e

Cat 3

Fuel & energy related activities

–

tCO2e

Cat 4

Upstream transportation & distribution

–

tCO2e

Cat 5

Waste generated in operations

–

tCO2e

Cat 6

Business travel

–

tCO2e

Cat 7

Employee commuting

–

tCO2e

Cat 8

Upstream leased assets

–

tCO2e

Cat 9

Downstream transportation & distribution

–

tCO2e

Cat 10

Processing of sold products

–

tCO2e

Cat 11

Use of sold products

–

tCO2e

Cat 12

End-of-life treatment of sold products

–

tCO2e

Cat 13

Downstream leased assets

–

tCO2e

Cat 14

Franchises

–

tCO2e

Cat 15

Investments

–

tCO2e
Structured data JSON-LD, Open Corporate Carbon Footprint Data Model Spreadsheet CSV

Open Corporate Carbon Footprint Data Model, by the Carbon Accounting Alliance with Murmurate Digital, Mycelium and Roundarc.

Contact Info

Website

www.astellas.eu

Address

–

Country

NLD

Browse carbon emissions data by industry

Jump straight into the sectors users explore most, or view all industries.

Financial Services Manufacturing Retail Food & Beverage Health Care Transportation

How scoring works

How the Mycelium Score is calculated

The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.

A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Astellas Pharma Europe Ltd (Branch/Related Entity)'s score sits at the top of this page and in the score panel.

How the Transparency Score is calculated

The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.

Astellas Pharma Europe Ltd (Branch/Related Entity) has disclosed the emissions categories that are material for its industry, so there's no single bucket dragging the transparency score down. The breakdown above shows full coverage across the categories that matter most for this kind of company.

Cover of Mycelium's scoring methodology white paper Read the full scoring methodology Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10. Download the white paper (PDF)

Astellas Pharma Europe Ltd (Branch/Related Entity) carbon emissions FAQs

What are Astellas Pharma Europe Ltd (Branch/Related Entity)'s carbon emissions?

In its 2022 reporting year, Astellas Pharma Europe Ltd (Branch/Related Entity) disclosed total emissions of 562,651 tCO2e across all scopes. Scope 3 accounted for the largest share, around 79% of the total.

Does Astellas Pharma Europe Ltd (Branch/Related Entity) report Scope 1, Scope 2 and Scope 3 emissions?

For 2022, Astellas Pharma Europe Ltd (Branch/Related Entity)'s available disclosure covers Scope 1 (61,171 tCO2e), Scope 2 (56,473 tCO2e). Figures not reported by the company are shown as modelled estimates and labelled as such.

How transparent is Astellas Pharma Europe Ltd (Branch/Related Entity)'s emissions reporting?

Astellas Pharma Europe Ltd (Branch/Related Entity) has a Mycelium transparency score of 10 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.

Learn more about our methodology and where this data comes from.